We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

92 hedge funds and large institutions have $1.08B invested in Sage Therapeutics in 2015 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

158% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 12

133% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 15

47% more capital invested

Capital invested by funds: $735M → $1.08B (+$345M)

26% more funds holding

Funds holding: 73 → 92 (+19)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
92
Holders Change
+19
Holders Change %
+26.03%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
31
Increased
35
Reduced
15
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$26.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$17.2M
3
Franklin Resources
Franklin Resources
California
+$16.7M
4
ORI
Oak Ridge Investments
Illinois
+$16.6M
5
DM
Deerfield Management
New York
+$14.3M

Top Sellers

Rank Fund Capital Flow
1
TRV
Third Rock Ventures
Massachusetts
-$82M
2
EC
EcoR1 Capital
California
-$16.3M
3
FCMI
Foresite Capital Management II
California
-$5.29M
4
NI
Numeric Investors
Massachusetts
-$1.79M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
51
TIAA CREF Investment Management
New York
$817K +$80.2K +1,865 +13%
TCM
52
Tekla Capital Management
Massachusetts
$753K +$430K +10,000 +200%
WMSA
53
Weiss Multi-Strategy Advisers
New York
$753K +$645K +15,000 New
Ameriprise
54
Ameriprise
Minnesota
$750K +$642K +14,930 New
Citadel Advisors
55
Citadel Advisors
Florida
$656K -$1.78M -41,408 -76%
AA
56
ALPS Advisors
Colorado
$646K +$553K +12,862 New
AP
57
AlpInvest Partners
Netherlands
$613K +$524K +12,195 New
DekaBank Deutsche Girozentrale
58
DekaBank Deutsche Girozentrale
Germany
$603K +$516K +12,000 New
Renaissance Technologies
59
Renaissance Technologies
New York
$558K +$477K +11,100 New
MAA
60
Managed Account Advisors
New Jersey
$543K +$439K +10,218 +1,712%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$530K -$4.3K -100 -0.9%
EEG
62
E.E. Geduld
$502K +$430K +10,000 New
Citigroup
63
Citigroup
New York
$454K -$370K -8,614 -49%
Charles Schwab
64
Charles Schwab
California
$402K – – –
ACP
65
Acuta Capital Partners
California
$402K +$344K +8,000 New
TA
66
Teachers Advisors
New York
$397K +$9.8K +228 +3%
CIA
67
Capital Impact Advisors
Massachusetts
$390K +$334K +7,768 New
SIM
68
Spark Investment Management
New York
$386K +$43K +1,000 +15%
Morgan Stanley
69
Morgan Stanley
New York
$331K +$200K +4,642 +237%
Swiss National Bank
70
Swiss National Bank
Switzerland
$276K – – –
Royal Bank of Canada
71
Royal Bank of Canada
Ontario, Canada
$264K +$105K +2,431 +86%
NV
72
Nair Vinay
$252K +$216K +5,025 New
SEI Investments
73
SEI Investments
Pennsylvania
$245K +$208K +4,828 +7,787%
Goldman Sachs
74
Goldman Sachs
New York
$235K -$1.26M -29,373 -86%
AIG
75
American International Group
New York
$182K – – –
1 2
3
4 5

SAGE Hedge Fund Activity: Q1 2015 in Review

92 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q1 2015, worth a combined $1.08B — up 47% from $735M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SAGE positions and 12 closed out — a net gain of 19 holders — while 35 added to existing stakes and 15 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $26.5M. The largest seller was Third Rock Ventures, cutting an estimated $82M.

  • 92 institutional investors held Sage Therapeutics (SAGE) as of Q1 2015, up from 73 in Q4 2014.
  • Funds reported $1.08B of Sage Therapeutics stock for Q1 2015, up 47% quarter-over-quarter.
  • 31 funds opened new Sage Therapeutics positions in Q1 2015 and 12 closed out, a net change of +19 holders.
  • The largest Sage Therapeutics buyer in Q1 2015 was JP Morgan Chase, an estimated $26.5M added.
  • The largest Sage Therapeutics seller in Q1 2015 was Third Rock Ventures, an estimated $82M sold.

Based on aggregated 13F filings for Q1 2015.